Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -76.82% is 48% above its 5-year average of -148.86%, near the high end of its 5-year range (-733.41%–-36.08%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.43% below its 12-month average of -65.98%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -76.82%.
RETURN ON EQUITY (ROE)
-76.82%
RETURN ON EQUITY (ROE) AVG TTM
-65.98%
RETURN ON EQUITY (ROE) AVG 3Y
-84.54%
RETURN ON EQUITY (ROE) AVG 5Y
-148.86%
RETURN ON EQUITY (ROE) AVG 10Y
-166.78%
RETURN ON EQUITY (ROE) AVG 15Y
-136.48%
RETURN ON EQUITY (ROE) AVG 20Y
-133.99%
CURRENT VS TTM AVG
-16.43%
CURRENT VS 3Y AVG
+9.13%
CURRENT VS 5Y AVG
+48.39%
CURRENT VS 10Y AVG
+53.94%
CURRENT VS 15Y AVG
+43.72%
CURRENT VS 20Y AVG
+42.67%
SECTOR MEDIAN · HEALTHCARE
-28.46%
median of 339 covered companies
CURRENT VS SECTOR MEDIAN
-169.92%
vs the sector median at left
ABVC BioPharma, Inc.
Market Cap
$25.48M
Return on Equity (ROE)
-76.82%
TTM Avg
-65.98%
3Y Avg
-84.54%
5Y Avg
-148.86%
Market Cap
$24.44M
Return on Equity (ROE)
-140.55%
TTM Avg
-62.02%
3Y Avg
-44.98%
5Y Avg
-43.41%
Market Cap
$28.43M
Return on Equity (ROE)
-124.64%
TTM Avg
-100.64%
3Y Avg
-80.07%
5Y Avg
-67.08%
Market Cap
$21.90M
Return on Equity (ROE)
-40.40%
TTM Avg
-55.95%
3Y Avg
-53.10%
5Y Avg
-83.38%
Market Cap
$20.93M
Return on Equity (ROE)
-2067.81%
TTM Avg
-13234.78%
3Y Avg
-6645.16%
5Y Avg
-6645.16%
Market Cap
$30.65M
Return on Equity (ROE)
-132.18%
TTM Avg
-94.77%
3Y Avg
-38.62%
5Y Avg
-46.78%
Market Cap
$30.92M
Return on Equity (ROE)
-120.40%
TTM Avg
-43.89%
3Y Avg
-83.08%
5Y Avg
-65.54%
Market Cap
$31.36M
Return on Equity (ROE)
-86.96%
TTM Avg
-27.78%
3Y Avg
5.60%
5Y Avg
57.54%
Market Cap
$18.82M
Return on Equity (ROE)
-117.98%
TTM Avg
-84.94%
3Y Avg
-64.05%
5Y Avg
-76.29%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ABVC BioPharma, Inc. (ABVC) | $25.48M | -76.82% | -65.98% | -84.54% | -148.86% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.44M | -140.55% | -62.02% | -44.98% | -43.41% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.43M | -124.64% | -100.64% | -80.07% | -67.08% |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -40.40% | -55.95% | -53.10% | -83.38% |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | -2067.81% | -13234.78% | -6645.16% | -6645.16% |
| CervoMed Inc. (CRVO)vs › | $30.65M | -132.18% | -94.77% | -38.62% | -46.78% |
| Context Therapeutics Inc. (CNTX)vs › | $30.92M | -120.40% | -43.89% | -83.08% | -65.54% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $31.36M | -86.96% | -27.78% | 5.60% | 57.54% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -117.98% | -84.94% | -64.05% | -76.29% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -3014.83% | -1589.49% | -1032.64% |
ROE
-76.8%
ROA
-40.7%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -76.82% |
| 2026-03-31 | -87.47% |
| 2025-12-31 | -78.34% |
| 2025-09-30 | -40.74% |
| 2025-06-30 | -46.55% |
| 2025-03-31 | -36.08% |
| 2024-12-31 | -321.50% |
| 2024-09-30 | -87.12% |
| 2024-06-30 | -123.05% |
| 2024-03-31 | -143.76% |
| 2023-12-31 | -676.64% |
| 2023-09-30 | -125.48% |
| 2023-03-31 | -733.41% |
| 2022-12-31 | -368.81% |
| 2022-09-30 | -329.32% |
| 2022-06-30 | -157.92% |
| 2022-03-31 | -187.19% |
| 2021-12-31 | -145.18% |
| 2021-09-30 | -88.06% |
| 2021-06-30 | -236.05% |
| 2021-03-31 | -175.65% |
| 2020-12-31 | -148.38% |
| 2020-06-30 | -212.33% |
| 2019-09-30 | -951.32% |
| 2016-06-30 | -453.29% |
| 2016-03-31 | -761.57% |
| 2015-12-31 | -33.01% |
| 2015-09-30 | -111.02% |
| 2015-06-30 | -4.71% |
| 2015-03-31 | 0.21% |
| 2014-12-31 | -3.69% |
| 2014-09-30 | -0.23% |
| 2006-06-30 | -64.05% |
| 2006-03-31 | -48.78% |
| 2005-12-31 | -43.95% |
| 2005-09-30 | -37.17% |
| 2005-06-30 | 2.47% |
| 2005-03-31 | -1.95% |
| 2004-12-31 | 2.91% |
| 2004-09-30 | -1.12% |
| 2004-06-30 | -57.64% |
